Exo officially enters handheld ultrasound race with launch of AI-powered Iris system
Exo officially enters handheld ultrasound race with launch of AI-powered Iris system
apark
Fri, 09/29/2023 - 12:15
FDA publishes proposal to increase regulatory oversight of lab-developed tests
FDA publishes proposal to increase regulatory oversight of lab-developed tests
chale
Fri, 09/29/2023 - 11:23
ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections
ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections
mbayer
Fri, 09/29/2023 - 10:08
Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together
Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together
apark
Fri, 09/29/2023 - 10:03
Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI
Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI
chale
Fri, 09/29/2023 - 09:56
Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial
Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial
ntaylor
Fri, 09/29/2023 - 09:24
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
jwaldron
Fri, 09/29/2023 - 06:07
Structure posts early oral obesity findings but delays larger readout after data collection mistake
Structure posts early oral obesity findings but delays larger readout after data collection mistake
ntaylor
Fri, 09/29/2023 - 04:12
Chutes & Ladders—Madrigal COO exits 2 weeks after new CEO Bill Sibold starts
Chutes & Ladders—Madrigal COO exits 2 weeks after new CEO Bill Sibold starts
mbayer
Thu, 09/28/2023 - 16:09
Revvity rolls out base editing reagents to increase access to preclinical DNA editing tech
Revvity rolls out base editing reagents to increase access to preclinical DNA editing tech
apark
Thu, 09/28/2023 - 13:16
U.S. cancer report details how diagnoses dropped during the COVID-19 pandemic
U.S. cancer report details how diagnoses dropped during the COVID-19 pandemic
chale
Thu, 09/28/2023 - 12:28
Karuna’s KarXT reaches FDA with hopes for first new schizophrenia drug mechanism in decades
Karuna’s KarXT reaches FDA with hopes for first new schizophrenia drug mechanism in decades
mbayer
Thu, 09/28/2023 - 10:31
Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round
Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round
apark
Thu, 09/28/2023 - 10:14
Yamaha revs up new US antibody profiling business Tuning Fork Bio
Yamaha revs up new US antibody profiling business Tuning Fork Bio
chale
Thu, 09/28/2023 - 10:07
Merck KGaA goes again in AI, expanding Quris toxicity prediction pact days after inking 2 deals
Merck KGaA goes again in AI, expanding Quris toxicity prediction pact days after inking 2 deals
ntaylor
Thu, 09/28/2023 - 09:24
Bionomics’ midphase PTSD trial hits primary endpoint, tripling its battered share price
Bionomics’ midphase PTSD trial hits primary endpoint, tripling its battered share price
ntaylor
Thu, 09/28/2023 - 07:09
Gritstone in line for $433M in BARDA funds to push mRNA COVID-19 shot into large-scale trial
Gritstone in line for $433M in BARDA funds to push mRNA COVID-19 shot into large-scale trial
jwaldron
Thu, 09/28/2023 - 05:55
Emmes calls in telehealth capabilities to expand eClinical platform
Emmes calls in telehealth capabilities to expand eClinical platform
jkeenan
Thu, 09/28/2023 - 00:53
Clario partners with CellCarta to streamline trial tissue, sample handling
Clario partners with CellCarta to streamline trial tissue, sample handling
jkeenan
Thu, 09/28/2023 - 00:26
To help drugs withstand the 'white hot heat' of human trials, scientists model the preclinic after the clinic
To help drugs withstand the 'white hot heat' of human trials, scientists model the preclinic after the clinic
hfloersh
Wed, 09/27/2023 - 17:22